Ischemia Reperfusion Injury Treatment Market is projected to grow at a CAGR of 6.1% from 2023 to 2033 & reach more than US$ 1580 Million by the end of 2033

Hospitals Expected to Procure 53% Market Share for Ischemia Reperfusion Injury Treatment Market. Europe Ischemia reperfusion injury treatment market size is expected to possess 41% market share in 2023. The increase in the incidence of ischemia-reperfusion injury (IRI) following surgical interventions such as organ transplantation and heart surgeries has propelled product demand.

/EIN News/ — NEWARK, Del, May 03, 2023 (GLOBE NEWSWIRE) — During the forecast period 2023 to 2033, the Ischemia Reperfusion Injury Treatment market is expected to grow at a value of 6.1% CAGR, according to Future Market Insights. By the year 2033, the global market for Ischemia Reperfusion Injury Treatment is expected to rise up to a market valuation of US$ 1580 Million. Growth of the market can be attributed to increasing in the number of surgeries and medical procedures that can cause ischemia reperfusion injury, as well as the development of innovative treatment options.

One of the key drivers of growth in the Ischemia Reperfusion Injury Treatment market is the development of new and more effective therapies. In recent years, researchers and medical professionals have made significant progress in understanding the underlying causes of ischemia reperfusion injury and identifying new treatment options. This includes therapies that target inflammation, oxidative stress, and other biological processes that contribute to tissue damage.

For Details on Vendors and Their Offerings – Request A Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-17043

Another factor driving market growth is an increase in healthcare spending in developing countries. As healthcare infrastructure improves in these regions, more patients are gaining access to treatment for ischemia reperfusion injury and other medical conditions. This is expected to drive demand for innovative therapies and treatments over the next few years.

Key Takeaways from the Market Study

• The global Ischemia Reperfusion Injury Treatment market is expected to grow with a 6.1% CAGR during 2023 to 2033.
• By end use, hospitals are expected to hold 53% of the market share in 2023 for Ischemia Reperfusion Injury Treatment market.
• North America is expected to possess 47% market share for Ischemia Reperfusion Injury Treatment market in 2023.
• Europe Ischemia Reperfusion Injury Treatment market size is expected to possess a 41% market share in 2023.

“With continued research and development, innovative new therapies and treatments will emerge, helping patients to manage and overcome this complex condition. This, in turn, is expected to favor the growth of the market.” states an FMI analyst

Competitive Landscape

Key players in the Ischemia Reperfusion Injury Treatment market are Amyndas Pharmaceuticals LLC, Angion, Bolder Biotechnology, Opsona Therapeutics Ltd., Pharming Group NV, Prolong Pharmaceuticals, Prothix BV, Stealth BioTherapeutics, Inc., Zealand Pharma A/S, Faraday Pharmaceuticals and SBI Pharmaceuticals

• Amyndas Pharmaceuticals has developed a proprietary drug delivery platform called Nano-EMulsion Delivery System (NEDS), which allows for targeted delivery of drugs to the affected tissues or organs. This platform technology enhances the efficacy of the drugs and reduces their toxicity.
• Angion Biomedica has developed a drug candidate called ANG-3777, which is a hepatocyte growth factor (HGF) mimetic. ANG-3777 has been shown to reduce inflammation, promote tissue regeneration, and improve organ function in preclinical studies of various types of acute organ injuries caused by ischemia reperfusion injury. ANG-3777 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of acute kidney injury.

Ask More About This Market’s Geographical Distribution Along With a Detailed Analysis of the Top Regions@ https://www.futuremarketinsights.com/ask-question/rep-gb-17043

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Ischemia Reperfusion Injury Treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Indication (Heart injury, Kidney injury, Intestine injury, Other injuries) End-user (Hospitals, Specialty Clinics) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)

Key Segments Profiled in the Ischemia Reperfusion Injury Treatment Industry Survey

Indication:

• Heart injury
• Kidney injury
• Intestine injury
• Other injuries

End-user:

• Hospitals
• Specialty Clinics

Table of Content

1. Executive Summary | Ischemia Reperfusion Injury Treatment Market

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 022 and Forecast, 2023 to 2033

4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 022 and Forecast 2023 to 2033, By Indication

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2018 to 2022

5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2023 to 2033

5.3.1. Heart Injury

5.3.2. Kidney Injury

5.3.3. Intestine Injury

5.3.4. Other Injury

5.4. Y-o-Y Growth Trend Analysis By Indication, 2018 to 2022

5.5. Absolute $ Opportunity Analysis By Indication, 2023 to 2033

Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market@ https://www.futuremarketinsights.com/checkout/17043

Have a Look at Related Reports of the Healthcare domain

Oxygen Conservation Devices Market Size: The oxygen conservation devices market is anticipated to have an effective CAGR of 11.1% during the period of 2022-2032.

Laparotomy Sponge Market Share: The market for laparotomy sponges is anticipated to document a steady CAGR of 6.6% across the forecast period ranging from 2022 to 2032.

Biodegradable Gloves Market Demand: The global biodegradable gloves market is expected to reach US$ 1.3 Bn in 2022, expanding at a CAGR of 23.0% over the forecast period.

Disposable Medical Gowns Market Trends: Disposable Medical Gowns Market analysis report by Future Market Insights shows that global sales of Disposable Medical Gowns Market in 2021 were held at US$ 2.5 Bn. With 17.5%, the projected market growth during 2022 – 2032

Joint Reconstruction Devices Market Analysis: Owing to the growing support from various governmental organizations, the market is likely to propel to US$ 41.5 Billion by 2032. The trade is projected at a 4.8% CAGR during the forecast period.

Laryngeal Mask Market Growth: Laryngeal Mask Market analysis report by Future Market Insights shows that global sales of Laryngeal Mask Market in 2021 were held at US$ 656.4 Mn. With 7.9%, the projected market growth from 2022 to 2032

Medical Equipment Reimbursement Market Forecast: Medical Equipment Reimbursement Market analysis report by Future Market Insights shows that global sales of the Medical Equipment Reimbursement Market in 2021 were held at US$ 414.1 Mn. With 12.9%, the projected market growth during 2022 – 2032

Internal Radiation Therapy Market Opportunities: Internal Radiation Therapy Market analysis report by Future Market Insights shows that global sales of the Internal Radiation Therapy Market in 2021 were held at US$ 892.9 Mn.

Patient Transport Services Market Overview: Patient Transport Services Market analysis report by Future Market Insights shows that global sales of Patient Transport Services Market in 2021 was held at US$ 34.1 Bn. With 12%,the projected market growth during 2022 to 2032.

Cancer Gene Therapy Market Outlook: The global demand for the cancer gene therapy is expected to increase at a 10.1% CAGR from 2022 to 2032, reaching US$ 2 Bn in 2022.

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization, and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel, and End Use over the next 10 years.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs